The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schleimer, R. P.
Right arrow Articles by MacGlashan, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schleimer, R. P.
Right arrow Articles by MacGlashan, D. W., Jr

The Journal of Immunology, Vol 143, Issue 4 1310-1317, Copyright © 1989 by American Association of Immunologists


ARTICLES

Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids

RP Schleimer, CP Derse, B Friedman, S Gillis, M Plaut, LM Lichtenstein and DW MacGlashan Jr
Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, MD 21239.

We have analyzed the effects of overnight culture of human basophils with a variety of cytokines in the presence or absence of the glucocorticoid dexamethasone. The 24-h culture of basophils with a range of concentrations of several cytokines (granulocyte-macrophage- CSF, TNF-alpha, IL-1, IL-2, and IL-4) had no effect either on anti-IgE- induced histamine release or the inhibitory effects of dexamethasone on histamine release. IFN-gamma enhanced postculture releasability of human basophils. The concentration range for this effect was from 50 to 50,000 U/ml and maximal enhancement of anti-IgE-induced basophil histamine release was approximately 200% of control. IFN-gamma did not increase the number of occupied or unoccupied Fc epsilon RI on human basophils, suggesting that the enhancement of histamine release is a result of an intrinsic increase in the releasability mechanism. rIL-3 also augmented basophil releasability (approximately 250% of control) by a mechanism independent of alterations in basophil cell surface IgE density. The increase in post culture releasability occurred in both partially purified basophils (12 to 90% purity) and mixed leukocytes (approximately 1% basophils) although it was more marked in the former. Enhanced postculture releasability after exposure to IL-3 occurred for both IgE-dependent (anti-IgE) and peptide-mediated (fmet-leu-phe) responses and included elevations in the release of both histamine and sulfidopeptide leukotriene, suggesting a global increase in releasability. Basophils cultured in the presence of IL-3 were insensitive to the inhibitory effects of dexamethasone; at 1,000 U/ml IL-3, dexamethasone inhibition of basophil mediator release was completely blocked. None of the other cytokines tested, with the exception of crude or partially purified IL-2 preparations, had this effect. IL-3 contamination may explain the ability of these partially purified "IL-2" preparations to block the inhibitory effects of dexamethasone, because this effect was abolished by a specific anti-IL- 3 antibody. These results suggest that IFN-gamma and IL-3 may modulate the response of human basophils in allergic reactions. Furthermore, increased local production of IL-3 may "prime" basophils for increased releasability and override inhibitory effects of elevated systemic glucocorticoids on human basophils. Finally, we conclude that the effects of glucocorticoids on human basophils may be in part mediated indirectly by effects on cells which produce cytokines, such as IFN- gamma and IL-3, that can modulate basophil function.


This article has been cited by other articles:


Home page
J. Immunol.Home page
L. Van Overtvelt, E. Wambre, B. Maillere, E. von Hofe, A. Louise, A. M. Balazuc, B. Bohle, D. Ebo, C. Leboulaire, G. Garcia, et al.
Assessment of Bet v 1-Specific CD4+ T Cell Responses in Allergic and Nonallergic Individuals Using MHC Class II Peptide Tetramers
J. Immunol., April 1, 2008; 180(7): 4514 - 4522.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Vilarino, K. Miura, and D. W. MacGlashan Jr
Acute IL-3 Priming Up-Regulates the Stimulus-Induced Raf-1-Mek-Erk Cascade Independently of IL-3-Induced Activation of Erk
J. Immunol., September 1, 2005; 175(5): 3006 - 3014.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Majlesi, P. Samorapoompichit, A. W. Hauswirth, G.-H. Schernthaner, M. Ghannadan, M. Baghestanian, A. Rezaie-Majd, R. Valenta, W. R. Sperr, H.-J. Buhring, et al.
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3
J. Leukoc. Biol., January 1, 2003; 73(1): 107 - 117.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. H. Falcone, H. Haas, and B. F. Gibbs
The human basophil: a new appreciation of its role in immune responses
Blood, December 15, 2000; 96(13): 4028 - 4038.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Z. ALLAKHVERDI, B. LAMKHIOUED, R. OLIVENSTEIN, Q. HAMID, and P. M. RENZI
CD8 Depletion-induced Late Airway Response Is Characterized by Eosinophilia, Increased Eotaxin, and Decreased IFN-gamma Expression in Rats
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1123 - 1131.
[Abstract] [Full Text]


Home page
FASEB J.Home page
C. A. AKDIS and K. BLASER
IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy
FASEB J, April 1, 1999; 13(6): 603 - 609.
[Abstract] [Full Text]


Home page
NEJMHome page
S. J. Galli
New Concepts about the Mast Cell
N. Engl. J. Med., January 28, 1993; 328(4): 257 - 265.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.